Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia

Hepatitis Research and Treatment

Volumn 2016, Issue , 2016, Pages

  Yohanes, Tsegaye ^a   Zerdo, Zerihun ^a   Chufamo, Nega ^a  

^a ARBA MINCH UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ABORTION; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SEXUALITY; VERTICAL TRANSMISSION;

EID: 85027989741     PISSN: 20901364     EISSN: 20901372     Source Type: Journal    
DOI: 10.1155/2016/9290163     Document Type: Article

References (38)

1. World Health Organization, "Hepatitis B," Fact Sheet 204, World Health Organization, Geneva, Switzerland, 2015, http://www.who.int/mediacentre/factsheets/fs204/en/.
2. M. J. U. Dahoma, A. A. Salim, R. Abdool et al., "HIV and substance abuse: the dual epidemics challenging Zanzibar," African Journal of Drug & Alcohol Studies, vol. 5, no. 2, pp. 131-139, 2006.
3. R. M. Merrill and B. D. Hunter, "Sero-prevalence of markers for hepatitis B viral infection," International Journal of Infectious Diseases, vol. 15, no. 2, pp. e78-e121, 2011.
4. A. O. Olaitan and L. G. Zamani, "Prevalence of hepatitis B virus and hepatitis C virus in ante-natal patients in Gwagwalada-Abuja, Nigeria," Report and Opinion, vol. 2, no. 7, pp. 48-50, 2010.
5. N.-C. Vu Lam, P. B. Gotsch, and R. C. Langan, "Caring for pregnant women and newborns with hepatitis B or C," American Family Physician, vol. 82, no. 10, pp. 1225-1229, 2010.
6. American College of Obstetricians and Gynecologists, "Viral hepatitis in pregnancy," Obstetrics & Gynecology, vol. 110, no. 4, pp. 941-956, 2007, ACOG Practice Bulletin No. 86.
7. Centers for Disease Control and Prevention, "Recommendations for identification and public health management of persons with chronic hepatitis B virus infection," Morbidity and Mortality Weekly Report, vol. 57, pp. 1-20, 2008.
8. S. Shukla, G. Mehta, M. Jais et al., "A prospective study on acute viral hepatitis in pregnancy; seroprevalence, and fetomaternal outcome of 100 cases," Journal of Bioscience and Technology, vol. 2, no. 3, pp. 279-286, 2011.
9. N. Leung, "Chronic hepatitis B in Asian women of childbearing age," Hepatology International, vol. 3, supplement 1, pp. 24-31, 2009.
10. MCHP-Maternal and Child Health Integrated Program, "Intersecting Epidemics: An Overview of the Causes of Maternal Death and Infectious Diseases," 2014, http://www.mchip.net/sites/default/files/Maternal%20Health-Infectious%20Diseases%20Overview%20Briefer.pdf.
11. FMOH, National Expanded Programme on Immunization Comprehensive Multi-Year Plan 2011-2015, Federal Ministry of Health, Addis Ababa, Ethiopia, 2010.
12. A. Bane, A. Patil, and M. Khatib, "Healthcare cost and access to care for viral hepatitis in Ethiopia," International Journal of Innovation and Applied Studies, vol. 9, no. 4, pp. 1718-1723, 2014.
13. W. J. Edmunds, A. Dejene, Y. Mekonnen, M. Haile, W. Alemnu, and D. J. Nokes, "The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa," Health Policy and Planning, vol. 15, no. 4, pp. 408-416, 2000.
14. E. Tsega, "Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments," Ethiopian Medical Journal, vol. 38, no. 2, pp. 131-141, 2000.
15. A. Abebe, D. J. Nokes, A. Dejene, F. Enquselassie, T. Messele, and F. T. Cutts, "Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control," Epidemiology and Infection, vol. 131, no. 1, pp. 757-770, 2003.
16. M. Awole and S. Gebre-Selassie, "Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia," Ethiopian Journal of Health Development, vol. 19, no. 1, pp. 45-50, 2005.
17. M. Seid, B. Gelaw, and A. Assefa, "Sero-prevalence of HBV and HCV infections among pregnant women attending antenatal care clinic at Dessie Referral Hospital, Ethiopia," Advances in Life Sciences and Health, vol. 1, no. 2, pp. 109-120, 2014.
18. A. Semaw, H. Awet, and M. Yohannes, "Sero-prevalence of hepatitis B surface antigen and associated factors among pregnant mothers attending antenatal care service, Mekelle, Ethiopia: evidence from institutional based quantitative cross-sectional study," World Academy of Science, Engineering and Technology: Medical and Health Sciences, vol. 2, no. 9, 2015.
19. E. Zemene, D. Yewhalaw, S. Abera, T. Belay, A. Samuel, and A. Zeynudin, "Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia," BMC Infectious Diseases, vol. 12, article 337, 2012.
20. WHO/EPI, "Protocol for assessing prevalence of hepatitis B infection in antenatal patients," Tech. Rep. WHO/EPI/GEN/90.6, World Health Organization, Geneva, Switzerland, 1990, http://www.who.int/iris/handle/10665/61617.
21. Y. Zenebe, W. Mulu, M. Yimer, and B. Abera, "Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study," BMC Infectious Diseases, vol. 14, no. 1, article 118, 2014.
22. S. Rashid, C. Kilewo, and S. Aboud, "Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es Salaam, Tanzania," Tanzania Journal of Health Research, vol. 1, no. 16, pp. 1-8, 2014.
23. O. C. Ezechi, O. O. Kalejaiye, C. V. Gab-Okafor et al., "Seroprevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV Infection," The Pan African Medical Journal, vol. 17, article 197, 2014.
24. O. Ugbebor, M. Aigbirior, F. Osazuwa, E. Enabudoso, and O. Zabayo, "The prevalence of hepatitis B and C viral infections among pregnant women," North American Journal of Medical Sciences, vol. 3, no. 5, pp. 238-241, 2011.
25. J. J. Noubiap, J. R. Nansseu, S. T. Ndoula, J. J. Bigna, A. M. Jingi, and J. Fokom-Domgue, "Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon," BMC Public Health, vol. 15, article 454, 2015.
26. B. MacLean, R. F. Hess, E. Bonvillain et al., "Seroprevalence of hepatitis B surface antigen among pregnant women attending the hospital for women & children in Koutiala, Mali," South African Medical Journal, vol. 102, no. 1, pp. 47-49, 2012.
27. K. S. Saraswathi and F. Aljabri, "The study of prevalence of Hepatitis B surface antigen during pregnancy in a tertiary care hospital, South India," Der Pharmacia Lettre, vol. 4, no. 3, pp. 983-985, 2012.
28. C. Pande, S. K. Sarin, S. Patra et al., "Prevalence, risk factors and virological profile of chronic hepatitis b virus infection in pregnant women in India," Journal of Medical Virology, vol. 83, no. 6, pp. 962-967, 2011.
29. O. M. Kolawole, A. A. Wahab, D. A. Adekanle, T. Sibanda, and A. I. Okoh, "Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria," Virology Journal, vol. 9, article 317, 2012.
30. E. A. Murad, S. M. Babiker, G. I. Gasim, D. A. Rayis, and I. Adam, "Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen," BMC Pregnancy and Childbirth, vol. 13, article 127, 2013.
31. T. M. Abdallah, M. H. Mohamed, and A. A. Ali, "Seroprevalence and epidemiological factors of hepatitis B virus (HBV) infection in Eastern Sudan," International Journal of Medicine and Medical Sciences, vol. 3, no. 7, pp. 239-241, 2011.
32. M. Motazakker, M. S. Nagadeh, F. Khalili et al., "Hepatitis B virus infection among pregnant women attending health care centers of Urmia," Journal of Guilan University of Medical Sciences, vol. 23, no. 89, pp. 45-50, 2014.
33. C. E. Onwuakor, V. C. Eze, I. U. Nwankwo, and J. O. Iwu,"Seroprevalence of hepatitis B surface antigen (HBsAg) amongst pregnant women attending antenatal clinic at the Federal Medical Centre Umuahia, Abia State, Nigeria," American Journal of Public Health Research, vol. 2, no. 6, pp. 255-259, 2014.
34. A. C. Eke, U. A. Eke, C. I. Okafor, I. U. Ezebialu, and C. Ogbuagu, "Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting," Virology Journal, vol. 8, article 12, 2011.
35. V. U. Usanga, L. Abia-Bassey, P. C. Inyang-Etoh, S. M. Udoh, F. Ani, and E. Archibong, "Prevalence of sexually transmitted diseases in pregnant and non-pregnant women in Calabar, cross river state, Nigeria," The Internet Journal of Gynecology and Obstetrics, vol. 14, no. 2, pp. 1-7, 2009.
36. G. Fisseha, "Young women sexual behaviour and self-reported sexually transmitted diseases in northern ethiopia: a cross sectional study," European Journal of Preventive Medicine, vol. 3, no. 3, pp. 55-62, 2015.
37. J. O. Alegbeleye, T. K. Nyengidik, and J. I. Ikimal, "Maternal and neonatal seroprevalence of hepatitis B surface antigen in a hospital based population in South-South, Nigeria," International Journal of Medicine and Medical Sciences, vol. 5, no. 5, pp. 241-246, 2013.
38. G. R. Pennap, E. T. Osanga, and A. Ubam, "Seroprevalence of hepatitis B surface antigen among pregnant women attending antenatal clinic in federal medical center Keffi, Nigeria," Research Journal of Medical Sciences, vol. 5, no. 2, pp. 80-82, 2011.